A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer | MicrobiomeTrials
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-09-30Est. Completion: 2029-03-29
Enrollment target: 52 participants
Locations
Research Site, Orlando, Florida, United States
Research Site, Tampa, Florida, United States
Research Site, Boston, Massachusetts, United States
Research Site, Grand Rapids, Michigan, United States
Research Site, Commack, New York, United States
Research Site, Providence, Rhode Island, United States
Research Site, Ghent, Belgium
Research Site, Toronto, Ontario, Canada
Research Site, Québec, Canada
Research Site, Beijing, China
Research Site, Chengdu, China
Research Site, Guangzhou, China
Research Site, Nanjing, China
Research Site, Chūōku, Japan
Research Site, Hirakata-shi, Japan
Research Site, Kashiwa, Japan
Research Site, Amsterdam, Netherlands
Research Site, Maastricht, Netherlands
Research Site, Seoul, South Korea
Research Site, Seoul, South Korea
Research Site, Barcelona, Spain
Other microbiome trials you might be interested in
Prostate CancerMetastatic Prostate CancerProstate Cancer (Post Prostatectomy)Prostate Cancer Patients Treated by RadiotherapyProstate Cancer Non-Metastatic
Prostate cancer is the second most common cancer among men. Many patients experience a significantly reduced quality of …